Renal · Year 2 · from Renal

Case 1: Diuretic Resistance in Heart Failure

Patient Presentation

Demographics: 68-year-old male

Chief Complaint: Worsening leg swelling despite taking "water pills"

History of Present Illness: The patient has heart failure with reduced ejection fraction (EF 30%) and is on furosemide 80 mg twice daily. Over the past 2 weeks, he has developed progressive lower extremity edema, a 12-pound weight gain, and increased dyspnea on exertion. He reports taking his medications regularly but notes his urine output has decreased.

Past Medical History:

  • Heart failure with reduced ejection fraction
  • Type 2 diabetes mellitus
  • CKD Stage 3b (baseline creatinine 2.0 mg/dL)

Medications:

  • Furosemide 80 mg twice daily
  • Carvedilol 25 mg twice daily
  • Lisinopril 20 mg daily
  • Spironolactone 25 mg daily
  • Metformin 500 mg twice daily

Physical Examination:

  • Blood pressure: 142/88 mmHg
  • Heart rate: 82 bpm
  • Weight: 98 kg (baseline 86 kg)
  • JVP: Elevated to 12 cm
  • Lungs: Bibasilar crackles
  • Cardiac: S3 gallop
  • Extremities: 3+ pitting edema to thighs

Workup and Results

Laboratory Studies:

  • Creatinine: 2.4 mg/dL (baseline 2.0)
  • BUN: 48 mg/dL
  • Potassium: 4.8 mEq/L
  • Sodium: 132 mEq/L
  • BNP: 1,850 pg/mL (elevated)

Clinical Image

Diagram illustrating loop diuretic action at the thick ascending limb of the loop of Henle, blocking the NKCC2 transporter and the mechanisms of diuretic resistance including nephron remodeling and distal tubule compensation.

Diagnosis

Acute Decompensated Heart Failure with Diuretic Resistance

Contributing factors:

  • Reduced GFR limiting drug delivery to tubule
  • Compensatory distal tubule sodium reabsorption
  • Possible poor oral bioavailability from gut edema

Discussion

This case illustrates diuretic resistance:

  • Loop Diuretics and GFR: The lecture describes how loop diuretics must reach the tubular lumen to work. In CKD, reduced GFR means less drug delivery; higher doses are needed to achieve effective tubular concentrations.
  • Furosemide Bioavailability: The lecture notes oral furosemide has only ~50% bioavailability, which worsens with gut edema. IV administration bypasses this limitation.
  • Distal Tubule Compensation: Chronic loop diuretic use causes hypertrophy of the distal convoluted tubule, increasing sodium reabsorption at this site. Adding a thiazide creates "sequential nephron blockade."
  • Metolazone: The lecture highlights that metolazone maintains efficacy at very low GFR, making it particularly useful for resistant edema in CKD patients.

Treatment Plan

  1. IV Diuretic Conversion:
  • Convert to IV furosemide (doubles effective dose)
  • 80 mg IV bolus, then 80 mg IV every 8 hours
  • OR continuous infusion 10-20 mg/hour
  1. Add Thiazide for Sequential Blockade:
  • Metolazone 5 mg 30 minutes before furosemide
  • Creates synergistic diuresis
  1. Monitoring:
  • Daily weights and strict I/O
  • Twice daily electrolytes (risk of profound hypokalemia)
  • Monitor creatinine (may worsen initially)
  1. Adjust Other Medications:
  • Continue spironolactone (helps prevent hypokalemia)
  • May need to hold lisinopril if creatinine rises >30%
  1. Discharge Plan:
  • Oral metolazone 2.5-5 mg PRN with furosemide
  • Sodium restriction <2 g/day
  • Daily weights at home

Teaching Points

  1. Loop diuretics block NKCC2 in thick ascending limb (reabsorbs 25% of filtered sodium)
  2. Furosemide oral bioavailability is only ~50%; IV doubles effective dose
  3. Diuretic resistance involves reduced delivery + distal compensation
  4. Metolazone maintains efficacy at very low GFR
  5. Sequential nephron blockade (loop + thiazide) overcomes resistance

All cases for this lecture as Markdown